last ten years, the prescription rate of inhibitors over cytotoxic chemotherapy has more than tripled according to the National Institute of Cancer. Cytotoxic chemotherapies are simply not targeted enough to most cancer cells and still too detrimental to the body as a whole. Indeed, in 2004, the Journal of